Tower Research Capital (TRC)’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84K | Sell |
256
-765
| -75% | -$4.71K | ﹤0.01% | 4759 |
|
|
2026
Q1 | $6.67K | Buy |
1,021
+651
| +176% | +$5.6K | ﹤0.01% | 4044 |
|
|
2025
Q4 | $2.88K | Buy |
+370
| New | +$9.59K | ﹤0.01% | 4460 |
|
|
2025
Q3 | – | Sell |
-20
| Closed | -$3.28K | – | 5592 |
|
|
2025
Q2 | $3.28K | Buy |
20
+2
| +11% | +$281 | ﹤0.01% | 4523 |
|
|
2025
Q1 | $2.51K | Buy |
+18
| New | +$5.24K | ﹤0.01% | 4541 |
|
|
2024
Q4 | – | Sell |
-18
| Closed | -$4.59K | – | 5973 |
|
|
2024
Q3 | $4.59K | Hold |
18
| – | – | ﹤0.01% | 4486 |
|
|
2024
Q2 | $7.56K | Buy |
18
+12
| +200% | +$7.93K | ﹤0.01% | 4450 |
|
|
2024
Q1 | $4.46K | Hold |
6
| – | – | ﹤0.01% | 4678 |
|
|
2023
Q4 | $5.32K | Hold |
6
| – | – | ﹤0.01% | 4852 |
|
|
2023
Q3 | $5.39K | Hold |
6
| – | – | ﹤0.01% | 4727 |
|
|
2023
Q2 | $12.3K | Buy |
+6
| New | +$13.7K | ﹤0.01% | 3889 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6239 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$3.55K | – | 6330 |
|
|
2022
Q3 | $5K | Sell |
1
-1
| -50% | -$7.56K | ﹤0.01% | 5169 |
|
|
2022
Q2 | $17K | Buy |
+2
| New | +$17.3K | ﹤0.01% | 3971 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5096 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5662 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5532 |
|
|
2021
Q2 | – | Sell |
-2
| Closed | -$89K | – | 5807 |
|
|
2021
Q1 | $87K | Buy |
+2
| New | +$115K | ﹤0.01% | 2694 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | -$29.3K | – | 4438 |
|
|
2020
Q3 | $44K | Buy |
+1
| New | +$39.6K | ﹤0.01% | 3587 |
|
|
2018
Q2 | – | Hold |
0
| – | -$1K | – | 4024 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3096 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3241 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 3407 |
|
|
2017
Q2 | – | Hold |
0
| – | -$1K | – | 3378 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 2843 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2666 |
|
|
2016
Q3 | – | Hold |
0
| – | -$10K | – | 4368 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 2837 |
|
|
2016
Q1 | – | Hold |
0
| – | -$5K | – | 4847 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3021 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1438 |
|
|
2015
Q2 | – | Hold |
0
| – | -$30K | – | 4964 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1908 |
|
Other funds holding DCOY
Tower Research Capital (TRC)'s DCOY Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its Decoy Therapeutics (DCOY) stake by 75% in Q2 2026, selling an estimated $4.71K and leaving 256 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #4759.
Tower Research Capital (TRC) first reported a position in DCOY in Q3 2020 and has held it in 15 quarters since. The position peaked at $87K in Q1 2021. 4 funds tracked by Wall St. Rank hold DCOY as of Q2 2026.
- Tower Research Capital (TRC) held 256 shares of Decoy Therapeutics worth $1.84K as of Q2 2026.
- Tower Research Capital (TRC) sold 765 Decoy Therapeutics shares in Q2 2026, an estimated $4.71K.
- Decoy Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4759 holding.
- Tower Research Capital (TRC) first reported a position in Decoy Therapeutics in Q3 2020 and has held it in 15 quarters since.
- Tower Research Capital (TRC)'s Decoy Therapeutics position peaked at $87K in Q1 2021.
- 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.